Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis

被引:147
作者
Kraemer, Richard
Delosea, Natascha
Ballinari, Pietro
Gallati, Sabina
Crameri, Reto
机构
[1] Univ Bern, Dept Pediat, CH-3010 Bern, Switzerland
[2] Univ Bern, Dept Psychiat, CH-3010 Bern, Switzerland
[3] Univ Bern, Div Human Genet, CH-3010 Bern, Switzerland
[4] Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland
关键词
allergic bronchopulmonary aspergillosis; Aspergillus fumigatus sensitization; cystic fibrosis; lung function; Pseudomonas aeruginosa infection;
D O I
10.1164/rccm.200603-423OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: The relationship between sensitization to Aspergillus fumigatus and progression of pulmonary function is not yet established in cystic fibrosis (CF). Objectives: We aimed to evaluate onset of A. fumigatus sensitization and development of allergic bronchopulmonary aspergillosis (ABPA), as well as to determine the physiologic factors of lung function influencing these mechanisms in CF. Methods: Serial annual lung function tests performed in 122 children with CF (62 males; 60 females; age: 6-18 yr) provided data pertaining to FRC measured by plethysmography, lung clearance index, volume of trapped gas, effective specific airway resistance, and forced expiratory indices (FEV1, FEF at 50% VC). Specific IgE to recombinant A. fumigatus allergens, rAspf1 and rAspf3, served as marker for sensitization, and to rAspf4 and rAspf6 as indications for a serologic ABPA, were clinically diagnosed (Nelson criteria). By linear mixed-effect model analysis, five patient groups, (1) not sensitized and free from Pseudomonas aeruginosa, (2) intermittently P. aeruginosa colonized, (3) chronically P. aeruginosa infected, (4) sensitized, and (5) with ABPA, were retrospectively evaluated. Measurements and Main Results: A. fumigatus sensitization was best reflected by increased rAspf1 +3-specific IgE levels, whereas, in most patients, sensitization was preceded by P. aeruginosa infection. Patients with ABPA demonstrated the most severe progression in all lung function parameters, and FEF at 50% VC, volume of trapped gas, and effective specific airway resistance were the best predictors (p < 0.0001). However, regarding distinction between sensitization to A. fumigatus and development of ABPA in the course of CF, chronic P. aeruginosa infection has to be taken into account. Conclusions: Airway narrowing, gas trapping, and small airway disease are the major targets for functional derangement in ABPA.
引用
收藏
页码:1211 / 1220
页数:10
相关论文
共 50 条
[1]   THE AGE AT ONSET OF CHRONIC PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS - PROGNOSTIC-SIGNIFICANCE [J].
AEBI, C ;
BRACHER, R ;
LIECHTIGALLATI, S ;
TSCHAPPELER, H ;
RUDEBERG, A ;
KRAEMER, R .
EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (09) :S69-S73
[2]  
Almeida Marina B., 2006, J. Pediatr. (Rio J.), V82, P215, DOI 10.2223/JPED.1479
[3]   Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA [J].
Casaulta, C ;
Flückiger, S ;
Crameri, R ;
Blaser, K ;
Schoeni, MH .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2005, 16 (03) :217-225
[4]  
Chauhan B, 1997, J IMMUNOL, V159, P4072
[5]   Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis [J].
Chauhan, B ;
Santiago, L ;
Hutcheson, PS ;
Schwartz, HJ ;
Spitznagel, E ;
Castro, M ;
Slavin, RG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (04) :723-729
[6]   Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis [J].
Corey, M ;
Edwards, L ;
Levison, H ;
Knowles, M .
JOURNAL OF PEDIATRICS, 1997, 131 (06) :809-814
[7]   Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis [J].
Crameri, R ;
Hemmann, S ;
Ismail, C ;
Menz, G ;
Blaser, K .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1211-1216
[8]   Recombinant Aspergillus fumigatus allergens:: From the nucleotide sequences to clinical applications [J].
Crameri, R .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 115 (02) :99-114
[9]  
Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO
[10]  
2-D